Issue Information
11 March 2021
Issue Information
11 March 2021
Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib
Arani Sathiyapalan, Kimberly Legault, Christian B. Pol, Brandon M. Meyers – 10 March 2021
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice
Hidenori Toyoda, Jennifer Leong, Charles Landis, Masanori Atsukawa, Tsunamasa Watanabe, Daniel Q. Huang, Joanne Liu, Sabrina Xin Zi Quek, Toru Ishikawa, Taeang Arai, Keisuke Yokohama, Makoto Chuma, Koichi Takaguchi, Haruki Uojima, Tomonori Senoo, Hansen Dang, Mayumi Maeda, Joseph Hoang, Richard H. Le, Satoshi Yasuda, Khin N. Thin, Sally Tran, Nicholas Chien, Linda Henry, Akira Asai, Shinya Fukunishi, Ramsey Cheung, Seng Gee Lim, Huy N. Trinh, Mindie H. Nguyen – 10 March 2021
The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma
Gajanan Kendre, Silke Marhenke, Georgina Lorz, Diana Becker, Tanja Reineke‐Plaaß, Tanja Poth, Karthikeyan Murugesan, Florian Kühnel, Norman Woller, Ralph M. Wirtz, Andreas Pich, Jens U. Marquardt, Michael Saborowski, Arndt Vogel, Anna Saborowski – 10 March 2021
An Experimental DUAL Model of Advanced Liver Damage
Raquel Benedé‐Ubieto, Olga Estévez‐Vázquez, Feifei Guo, Chaobo Chen, Youvika Singh, Helder I. Nakaya, Manuel Gómez del Moral, Arantza Lamas‐Paz, Laura Morán, Nuria López‐Alcántara, Johanna Reissing, Tony Bruns, Matías A. Avila, Eva Santamaría, Marina S. Mazariegos, Marius Maximilian Woitok, Ute Haas, Kang Zheng, Ignacio Juárez, José Manuel Martín‐Villa, Iris Asensio, Javier Vaquero, Maria Isabel Peligros, Josepmaria Argemi, Ramón Bataller, Javier Ampuero, Manuel Romero Gómez, Christian Trautwein, Christian Liedtke, Rafael Bañares, Francisco Javier Cubero, Yulia A.
Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis B
Edward J. Gane, Hyung Joon Kim, Kumar Visvanathan, Yoon Jun Kim, Anh‐Hoa Nguyen, Jeffrey J. Wallin, Diana Y. Chen, Circe McDonald, Priyanka Arora, Susanna K. Tan, Anuj Gaggar, Stuart K. Roberts, Young‐Suk Lim – 10 March 2021
Dual‐Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma
Kui Chen, Andre Gorgen, Avrilynn Ding, Lulu Du, Keruo Jiang, Yu Ding, Gonzalo Sapisochin, Anand Ghanekar – 10 March 2021 – Hepatocellular carcinoma (CC) is a common and deadly cancer with complex molecular pathogenesis. Little is known about dual‐specificity phosphatases (DUSPs) in HCC. We investigated DUSP9 expression in human HCC, associations between DUSP9 and patient outcomes, and effects of altered DUSP9 expression on HCC biology. We studied public data sets as well as 196 patients at our institution who had HCC resections.
Post–Liver Transplant Early Allograft Dysfunction Modifies the Effect of Pre–Liver Transplant Renal Dysfunction on Post–Liver Transplant Survival
Hani M. Wadei, Andrew P. Keaveny, C. Burcin Taner, Liu Yang, Martin L. Mai, David O. Hodge, Launia J. White, Shennen A. Mao, Tambi Jarmi, Kristopher P. Croome – 8 March 2021 – Pre–liver transplantation (LT) renal dysfunction is associated with poor post‐LT survival. We studied whether early allograft dysfunction (EAD) modifies this association. Data on 2,856 primary LT recipients who received a transplant between 1998 and 2018 were retrospectively reviewed. Patients who died within the first post‐LT week or received multiorgan transplants and previous LT recipients were excluded.